"Information Technology Methodology for Patient Motivation in Diabetes Management."
NCT ID: NCT00727896
Last Updated: 2011-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
200 participants
INTERVENTIONAL
2008-08-31
2010-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Motivation of patients to adhere to treatment is difficult in clinical practice. It is well documented that majority of patients do not reach the glycaemic targets even in the centres of excellence. Regular short service messages (SMS) through cell phones could have a positive effect on behaviour and adherence to life style changes and compliance to drugs. It may be practical and feasible to use information technology as an effective and simple tool for motivating patients to adhere to the prescribed treatment regimen.
In diabetic patients, frequent reminders regarding the need for adherence to LSM and drugs by the medical professionals will improve the compliance.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Strategies for Translating Self-management Support Into Primary Care
NCT01945918
Enhancing Self-Management Support in Diabetes Through Patient Engagement
NCT02834923
Use of a Smart-phone Based Medication Adherence Platform to Improve Outcomes in Uncontrolled Non-insulin Dependent Diabetes Among Veterans
NCT05789706
Chronic Care Management/Patient Relationship Management Proof of Concept
NCT01182480
Short Message Service (SMS) Impact on Patient Compliance Receiving Long Term Lipid Lowering Therapy With Statins
NCT00829348
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Out of total number of 200, consecutive randomization of 100 patients each to SMS or usual care arms will be done. Patients in the SMS group will get SMS once in 3 days as a reminder. Patients will be reviewed at 3, 6, 9 and 12 months from the date of randomization
Fasting and 2hr postprandial glucose and HbA1c will be tested during each visit.
At baseline and at the end of the study, lipids, and renal function test will also be done. A validated questionnaire will be used to assess physical activity, diet habits, adherence to drug prescriptions and frequency of monitoring of blood glucose. . Body weight, blood pressure, biochemical variables, scores for diet and physical activity and compliance to drugs, will be compared using students 't' test or chi-square test as relevant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 is experimental with SMS
Arm 1 is experimental with SMS intervention
Pre-coded messages
Earlier life style modification and existing drug therapy was used and now SMS is added as a tool for reminder
2 is (active comparator) standard care
Arm 2 is the usual care arm (standard care)
Diabetes Treatment
Life style modification and drug therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pre-coded messages
Earlier life style modification and existing drug therapy was used and now SMS is added as a tool for reminder
Diabetes Treatment
Life style modification and drug therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HbA1C ranging 8.0-10.0%
* Patients either receiving OHA and / or insulin
Exclusion Criteria
* Patients with history of blindness, decreased vision
* Serious vascular complications :
* Cancer
30 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
INDIA DIABETES RESEARCH FOUNDATION (IDRF) and Dr. A. Ramachandran's Diabetes Hospitals (ARH)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Samith A Shetty, M.B.B.S, MDRC
Role: PRINCIPAL_INVESTIGATOR
India Diabetes Research Foundation (IDRF) and Dr.A.Ramachandran's Diabetes Hospitals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
India Diabetes Research Foundation and Dr.A.Ramachandran's Diabetes Hospitals
Chennai, Tamil Nadu, India
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V; Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006 Feb;49(2):289-97. doi: 10.1007/s00125-005-0097-z. Epub 2006 Jan 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SMS001IDRF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.